• Study on the Safety and Tolerability of TransCon IL-2 β/γ, Pembrolizumab, and Chemotherapy in Adults with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium Italy Poland Spain
  • Study on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression

    Not recruiting

    2 1 1 1
    France Italy Spain
  • Study Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Greece +7
  • Study on the Safety and Effects of BAY 2599023 (Peboctocogene Camaparvovec) for Adults with Severe Hemophilia A

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany The Netherlands
  • Study on Holmium-166 TARE and Maintenance Therapy with Capecitabine, Bevacizumab, and Drug Combination for Patients with Unresectable Liver-Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study of JDQ443 and Ribociclib in Combination for Adult Patients with Advanced Solid Tumors with KRAS G12C Mutation

    Not recruiting

    1 1 1 1
    Belgium France Germany Italy Spain
  • Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Germany
  • Study on the Effects of Inhaled ETD001 for People with Cystic Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    France Germany Italy
  • Study on the Long-Term Safety of Darvadstrocel for Adults with Crohn’s Disease and Complex Perianal Fistulas

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Czechia France Germany Spain
  • Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

    Not recruiting

    3 1 1
    Investigated Drugs:
    Czechia Denmark France Germany Hungary Italy +3

powered by